Lok Wai Cola Ho

Title: Innovations of Lok Wai Cola Ho in Nanoparticle Therapeutics

Introduction

Lok Wai Cola Ho is an innovative inventor based in Hong Kong, CN. He has made significant contributions to the field of nanoparticle therapeutics, particularly in the treatment of skin conditions such as psoriasis. His work focuses on enhancing the delivery of anti-psoriatic drugs through advanced nanoparticle technology.

Latest Patents

Lok Wai Cola Ho holds a patent for a self-therapeutic nanoparticle designed for enhanced topical delivery to skin keratinocytes and treating skin inflammation. The patent describes a composition that includes an anti-psoriatic drug, which consists of a core made of at least one gold nanoparticle. This core is surrounded by a shell of polyethylene glycol (PEG) strands that are conjugated to the core, along with a plurality of alkyl groups attached to the PEG shell. The configuration of these components is optimized to improve the distribution of the composition within skin cells, enhancing skin permeability and facilitating entry into keratinocytes. The patent also outlines methods for modulating the effectiveness of the anti-psoriatic drug to inhibit the development of psoriasis or treat existing psoriasis phenotypes.

Career Highlights

Lok Wai Cola Ho is affiliated with The Chinese University of Hong Kong, where he conducts research and develops innovative therapeutic solutions. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from skin conditions.

Collaborations

He collaborates with notable colleagues, including Chung Hang Jonathan Choi and Ruifang Han, contributing to a dynamic research environment focused on advancing therapeutic technologies.

Conclusion

Lok Wai Cola Ho's innovative work in nanoparticle therapeutics represents a significant advancement in the treatment of skin inflammation and psoriasis. His contributions are paving the way for more effective and targeted therapies in dermatology.